S. Res. 732 (IS) - Expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Ms. Warren (for herself, Ms. Baldwin, Mr. Schumer, Mr. Wyden, Mrs. Murray, Ms. Smith, Ms. Alsobrooks, Mr. Bennet, Mr. Blumenthal, Ms. Blunt Rochester, Mr. Booker, Ms. Cantwell, Mr. Coons, Ms. Cortez Masto, Ms. Duckworth, Mr. Durbin, Mr. Fetterman, Mr. Gallego, Mrs. Gillibrand, Ms. Hassan, Mr. Heinrich, Mr. Hickenlooper, Ms. Hirono, Mr. Kaine, Mr. Kelly, Mr. Kim, Mr. King, Ms. Klobuchar, Mr. Luján, Mr. Markey, Mr. Merkley, Mr. Murphy, Mr. Ossoff, Mr. Padilla, Mr. Peters, Mr. Reed, Ms. Rosen, Mr. Sanders, Mr. Schatz, Mr. Schiff, Ms. Slotkin, Mrs. Shaheen, Mr. Van Hollen, Mr. Warner, Mr. Warnock, Mr. Welch, and Mr. Whitehouse) submitted the following resolution; which was referred to the Committee on Health, Education, Labor, and Pensions
Expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Tammy Baldwin
(WI); Charles E. Schumer
(NY); Ron Wyden
(OR); Patty Murray
(WA); Tina Smith
(MN); Angela D. Alsobrooks
(MD); Michael F. Bennet
(CO); Richard Blumenthal
(CT); Lisa Blunt Rochester
(DE); Cory A. Booker
(NJ); Maria Cantwell
(WA); Christopher A. Coons
(DE); Catherine Cortez Masto
(NV); Tammy Duckworth
(IL); Richard J. Durbin
(IL); John Fetterman
(PA); Ruben Gallego
(AZ); Kirsten E. Gillibrand
(NY); Margaret Wood Hassan
(NH); Martin Heinrich
(NM); John W. Hickenlooper
(CO); Mazie K. Hirono
(HI); Tim Kaine
(VA); Mark Kelly
(AZ); Andy Kim
(NJ); Angus S. King Jr.
(ME); Amy Klobuchar
(MN); Ben Ray Lujan
(NM); Edward J. Markey
(MA); Jeff Merkley
(OR); Christopher Murphy
(CT); Jon Ossoff
(GA); Alex Padilla
(CA); Gary C. Peters
(MI); Jack Reed
(RI); Jacky Rosen
(NV); Bernard Sanders
(VT); Brian Schatz
(HI); Adam B. Schiff
(CA); Elissa Slotkin
(MI); Jeanne Shaheen
(NH); Chris Van Hollen
(MD); Mark R. Warner
(VA); Raphael G. Warnock
(GA); Peter Welch
(VT); Sheldon Whitehouse
(RI)
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. S. Res. 732. 119th
Cong., 2nd
sess., Introduced in Senate May 14, 2026. https://www.govinfo.gov/app/details/BILLS-119sres732is.
APA
Congress, Senate (2026, May 14). Expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. (S. Res. 732 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119sres732is.
MLA
United States, Congress, Senate. Expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119sres732is. 119th Congress, S. Res. 732, Introduced in Senate 14 May. 2026.
Bluebook
S.Res.732 - 119th Congress (2025-2026): Expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science., S.Res.732, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119sres732is.
